Darmstadt, Germany

Jens Budak



Average Co-Inventor Count = 6.0

ph-index = 1

Forward Citations = 4(Granted Patents)


Company Filing History:


Years Active: 2002

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Innovations by Jens Budak: A Look into His Contributions to Patents

Introduction

Jens Budak, an accomplished inventor based in Darmstadt, Germany, has made significant strides in the field of pharmaceutical chemistry. With a focus on innovative processes, Budak holds a patent that highlights his expertise and creativity in developing unique compounds.

Latest Patents

Budak's sole patent is titled "Method for producing enantiomer-free N-methyl-N-[(1S)-1-phenyl-2-((3S)-3-hydroxypyrolidine-1-yl)ethyl]-2,2-diphenylacetamide." This invention details a novel process for the alternative preparation of N-methyl-N-[(1S)-1-phenyl-2-((3S)-3-hydroxypyrrolidin-1-yl)ethyl]-2,2-diphenylacetamide, as well as its counterpart, N-methyl-N-[(1R)-1-phenyl-2-((3R)-3-hydroxypyrrolidin-1-yl)ethyl]-2,2-diphenylacetamide. Additionally, his patent includes the innovative compounds N-methyl-N-[(1S)-1-phenyl-2-((3S)-3-hydroxypyrrolidin-1-yl)ethane] and N-methyl-N-[(1R)-1-phenyl-2-((3R)-3-hydroxypyrrolidin-1-yl)ethane], which serve as intermediates in his process.

Career Highlights

Jens Budak has forged a career at Merck Patent GmbH, where his contributions to pharmaceutical innovations have gained recognition. His work not only reflects his skills as an inventor but also demonstrates the potential impact of his research on future therapeutic applications.

Collaborations

Within the dynamic environment of Merck, Budak collaborates with esteemed colleagues such as Andreas Bathe and Bernd Helfert. This collaborative spirit encourages knowledge-sharing and fosters an innovative atmosphere, enabling them to tackle complex scientific challenges effectively.

Conclusion

Jens Budak's patent exemplifies the ingenuity and scientific rigor that characterize modern pharmaceutical research. His contributions to the field underscore the importance of innovation in developing new therapeutic options and highlight the collaborative efforts within Merck Patent GmbH. As Budak continues his work, the implications of his inventions may pave the way for future advancements in pharmaceutical chemistry.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…